Acadian Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$95.3M Buy
887,478
+281,249
+46% +$30.2M 0.2% 110
2025
Q1
$61.1M Buy
606,229
+492,891
+435% +$49.7M 0.17% 122
2024
Q4
$10.1M Buy
113,338
+95,227
+526% +$8.5M 0.03% 352
2024
Q3
$1.52M Sell
18,111
-23,117
-56% -$1.94M ﹤0.01% 821
2024
Q2
$3.17M Sell
41,228
-52,030
-56% -$4M 0.01% 631
2024
Q1
$6.38M Buy
93,258
+43,916
+89% +$3.01M 0.02% 409
2023
Q4
$2.85M Buy
49,342
+22,411
+83% +$1.29M 0.01% 589
2023
Q3
$1.42M Sell
26,931
-72,673
-73% -$3.83M 0.01% 776
2023
Q2
$5.38M Buy
99,604
+94,454
+1,834% +$5.11M 0.02% 440
2023
Q1
$257K Buy
+5,150
New +$257K ﹤0.01% 1200
2022
Q4
Sell
-38,878
Closed -$1.5M 1780
2022
Q3
$1.5M Sell
38,878
-136,686
-78% -$5.28M 0.01% 703
2022
Q2
$6.54M Buy
175,564
+174,767
+21,928% +$6.51M 0.03% 353
2022
Q1
$35K Buy
+797
New +$35K ﹤0.01% 1504
2021
Q4
Sell
-15,163
Closed -$656K 1682
2021
Q3
$656K Sell
15,163
-2,208
-13% -$95.5K ﹤0.01% 969
2021
Q2
$743K Buy
17,371
+12,515
+258% +$535K ﹤0.01% 1021
2021
Q1
$187K Sell
4,856
-9,761
-67% -$376K ﹤0.01% 1521
2020
Q4
$525K Sell
14,617
-6,372
-30% -$229K ﹤0.01% 1220
2020
Q3
$802K Buy
20,989
+13,199
+169% +$504K ﹤0.01% 984
2020
Q2
$274K Hold
7,790
﹤0.01% 1385
2020
Q1
$254K Buy
7,790
+3,346
+75% +$109K ﹤0.01% 1142
2019
Q4
$201K Buy
+4,444
New +$201K ﹤0.01% 1291
2019
Q2
Sell
-2,569
Closed -$99K 1830
2019
Q1
$99K Sell
2,569
-3,639
-59% -$140K ﹤0.01% 1520
2018
Q4
$219K Sell
6,208
-7,062
-53% -$249K ﹤0.01% 1094
2018
Q3
$511K Buy
13,270
+6,911
+109% +$266K ﹤0.01% 874
2018
Q2
$208K Buy
+6,359
New +$208K ﹤0.01% 1074